Supplementary Data S2 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics

<p>Includes the list of peptides derived from NSM identified at 0.02 FDR and ALC>=30</p>

Guardat en:

Dades bibliogràfiques
Autor principal:	Maria Lozano-Rabella (15056515) (author)
Altres autors:	Andrea Garcia-Garijo (15056518) (author), Jara Palomero (15056521) (author), Anna Yuste-Estevanez (15056524) (author), Florian Erhard (15056527) (author), Roc Farriol-Duran (15056530) (author), Juan Martín-Liberal (15056533) (author), Maria Ochoa-de-Olza (15056536) (author), Ignacio Matos (15056539) (author), Jared J. Gartner (15046103) (author), Michael Ghosh (15056542) (author), Francesc Canals (15056545) (author), August Vidal (15056548) (author), Josep Maria Piulats (15056551) (author), Xavier Matías-Guiu (15056554) (author), Irene Brana (15056557) (author), Eva Muñoz-Couselo (14957498) (author), Elena Garralda (15039090) (author), Andreas Schlosser (15056560) (author), Alena Gros (15056563) (author)
Publicat:	2025
Matèries:	Cancer Therapeutic Research and Development Immuno-oncology Immunology Immune responses to cancer Tumor antigens/neoantigens Immunotherapy Cancer vaccines Cellular immunotherapy Translational Research
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars